Emcure Pharmaceuticals share price saw strong debut with stock opening at ₹1,325.05, 31.45% higher than issue price. Grey market premium at +300 indicated investors willing to pay more. IPO listing price estimated at ₹1,308 per share, 29.76% higher than issue price of ₹1,008.
Emcure Pharmaceuticals share price made a strong debut on the bourses today. On NSE and BSE, Emcure Pharmaceuticals share price opened at ₹1,325.05 per share, 31.45% higher than the issue price of ₹1,008.
Market experts anticipated Emcure Pharmaceuticals share price to open in the range of ₹1,370 to ₹1,390 apiece.
All sections of the Emcure Pharma IPO were oversubscribed on the third day of the bidding process, with non-institutional investors leading the way. According to BSE data, Emcure Pharmaceuticals IPO subscription status was 67.87 times.
The retail investors component was booked 7.21 times, while the non-institutional investors received a subscription 48.32 times. The employee component has 8.81 times as many subscriptions as the qualified institutional buyer (QIB), with 195.83 subscriptions.